INS and Charcot-Marie-Tooth disease type 3: By modulating rsFC between the mPFC and postcentral areas, intranasal insulin may enhance motor and sensory function in individuals with DSN, presenting a promising avenue for future research into the neural mechanisms underlying DSN.